APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Anthrax Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Veterinary Anthrax Vaccines Market Outlook and Growth Opportunities 2026

20 December 2025194 pages

Choose your research edition.

Industry ResearchVeterinary Anthrax Vaccines Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Anthrax Vaccines Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Veterinary Anthrax Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Anthrax Vaccines Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Anthrax Vaccines Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Veterinary Anthrax Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Veterinary Anthrax Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Anthrax Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Anthrax Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Veterinary Anthrax Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Veterinary Anthrax Vaccines market include JOVAC, Intervac (PVT) Ltd, Institute for Biological Products, Indian Immunologicals Limited, Empresa Colombiana de Productos Veterinarios S.A, Colorado Serum Company, Ceva Sante Animale, Centro Diagnostico Veterinario and Central Veterinary Control and Research Institute, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Veterinary Anthrax Vaccines market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Anthrax Vaccines and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Anthrax Vaccines revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Veterinary Anthrax Vaccines market.

Veterinary Anthrax Vaccines Segment by Company

JOVAC

Intervac (PVT) Ltd

Institute for Biological Products

Indian Immunologicals Limited

Empresa Colombiana de Productos Veterinarios S.A

Colorado Serum Company

Ceva Sante Animale

Centro Diagnostico Veterinario

Central Veterinary Control and Research Institute

Botswana Vaccine Institute

Biogenesis Bago SA

Bayer Sanidad Animal

Agrovet

Veterinary Anthrax Vaccines Segment by Type

Cell Free PA Vaccines

Live Vaccines

Veterinary Anthrax Vaccines Segment by Application

Cow

Sheep

Swine

Other

Veterinary Anthrax Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Veterinary Anthrax Vaccines status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Veterinary Anthrax Vaccines key companies, revenue, market share, and recent developments.

3. To split the Veterinary Anthrax Vaccines breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Veterinary Anthrax Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary Anthrax Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary Anthrax Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Anthrax Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Anthrax Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Anthrax Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Anthrax Vaccines industry.

Chapter 3: Detailed analysis of Veterinary Anthrax Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Veterinary Anthrax Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Veterinary Anthrax Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary Anthrax Vaccines Industry Trends Table 2. Veterinary Anthrax Vaccines Industry Drivers Table 3. Veterinary Anthrax Vaccines Industry Opportunities and Challenges Table 4. Veterinary Anthrax Vaccines Industry Restraints Table 5. Global Veterinary Anthrax Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary Anthrax Vaccines Revenue Share by Company (2021-2026) Table 7. Global Veterinary Anthrax Vaccines Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Veterinary Anthrax Vaccines Key Company Manufacturing Base & Headquarters Table 9. Global Veterinary Anthrax Vaccines Company, Product Type & Application Table 10. Global Veterinary Anthrax Vaccines Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Veterinary Anthrax Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cell Free PA Vaccines Table 15. Significant Companies of Live Vaccines Table 16. Global Veterinary Anthrax Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Veterinary Anthrax Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Veterinary Anthrax Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Veterinary Anthrax Vaccines Sales Value Share by Type (2021-2026) Table 20. Global Veterinary Anthrax Vaccines Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Cow Table 22. Significant Companies of Sheep Table 23. Significant Companies of Swine Table 24. Significant Companies of Other Table 25. Global Veterinary Anthrax Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Veterinary Anthrax Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Veterinary Anthrax Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Veterinary Anthrax Vaccines Sales Value Share by Application (2021-2026) Table 29. Global Veterinary Anthrax Vaccines Sales Value Share by Application (2027-2032) Table 30. Global Veterinary Anthrax Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Veterinary Anthrax Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Veterinary Anthrax Vaccines Sales Value Share by Region (2021-2026) Table 33. Global Veterinary Anthrax Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Veterinary Anthrax Vaccines Sales Value Share by Region (2027-2032) Table 35. Global Veterinary Anthrax Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Veterinary Anthrax Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Veterinary Anthrax Vaccines Sales Value Market Share by Country (2021-2026) Table 38. Global Veterinary Anthrax Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Veterinary Anthrax Vaccines Sales Value Market Share by Country (2027-2032) Table 40. JOVAC Company Information Table 41. JOVAC Business Overview Table 42. JOVAC Veterinary Anthrax Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. JOVAC Veterinary Anthrax Vaccines Product Portfolio Table 44. JOVAC Recent Development Table 45. Intervac (PVT) Ltd Company Information Table 46. Intervac (PVT) Ltd Business Overview Table 47. Intervac (PVT) Ltd Veterinary Anthrax Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Intervac (PVT) Ltd Veterinary Anthrax Vaccines Product Portfolio Table 49. Intervac (PVT) Ltd Recent Development Table 50. Institute for Biological Products Company Information Table 51. Institute for Biological Products Business Overview Table 52. Institute for Biological Products Veterinary Anthrax Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Institute for Biological Products Veterinary Anthrax Vaccines Product Portfolio Table 54. Institute for Biological Products Recent Development Table 55. Indian Immunologicals Limited Company Information Table 56. Indian Immunologicals Limited Business Overview Table 57. Indian Immunologicals Limited Veterinary Anthrax Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Indian Immunologicals Limited Veterinary Anthrax Vaccines Product Portfolio Table 59. Indian Immunologicals Limited Recent Development Table 60. Empresa Colombiana de Productos Veterinarios S.A Company Information Table 61. Empresa Colombiana de Productos Veterinarios S.A Business Overview Table 62. Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Product Portfolio Table 64. Empresa Colombiana de Productos Veterinarios S.A Recent Development Table 65. Colorado Serum Company Company Information Table 66. Colorado Serum Company Business Overview Table 67. Colorado Serum Company Veterinary Anthrax Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Colorado Serum Company Veterinary Anthrax Vaccines Product Portfolio Table 69. Colorado Serum Company Recent Development Table 70. Ceva Sante Animale Company Information Table 71. Ceva Sante Animale Business Overview Table 72. Ceva Sante Animale Veterinary Anthrax Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Ceva Sante Animale Veterinary Anthrax Vaccines Product Portfolio Table 74. Ceva Sante Animale Recent Development Table 75. Centro Diagnostico Veterinario Company Information Table 76. Centro Diagnostico Veterinario Business Overview Table 77. Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Product Portfolio Table 79. Centro Diagnostico Veterinario Recent Development Table 80. Central Veterinary Control and Research Institute Company Information Table 81. Central Veterinary Control and Research Institute Business Overview Table 82. Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Product Portfolio Table 84. Central Veterinary Control and Research Institute Recent Development Table 85. Botswana Vaccine Institute Company Information Table 86. Botswana Vaccine Institute Business Overview Table 87. Botswana Vaccine Institute Veterinary Anthrax Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Botswana Vaccine Institute Veterinary Anthrax Vaccines Product Portfolio Table 89. Botswana Vaccine Institute Recent Development Table 90. Biogenesis Bago SA Company Information Table 91. Biogenesis Bago SA Business Overview Table 92. Biogenesis Bago SA Veterinary Anthrax Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Biogenesis Bago SA Veterinary Anthrax Vaccines Product Portfolio Table 94. Biogenesis Bago SA Recent Development Table 95. Bayer Sanidad Animal Company Information Table 96. Bayer Sanidad Animal Business Overview Table 97. Bayer Sanidad Animal Veterinary Anthrax Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Bayer Sanidad Animal Veterinary Anthrax Vaccines Product Portfolio Table 99. Bayer Sanidad Animal Recent Development Table 100. Agrovet Company Information Table 101. Agrovet Business Overview Table 102. Agrovet Veterinary Anthrax Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Agrovet Veterinary Anthrax Vaccines Product Portfolio Table 104. Agrovet Recent Development Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Veterinary Anthrax Vaccines Product Image Figure 2. Global Veterinary Anthrax Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Anthrax Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Anthrax Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cell Free PA Vaccines Image Figure 8. Live Vaccines Image Figure 9. Global Veterinary Anthrax Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Veterinary Anthrax Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Veterinary Anthrax Vaccines Sales Value Share by Type (2021-2032) Figure 12. Cow Image Figure 13. Sheep Image Figure 14. Swine Image Figure 15. Other Image Figure 16. Global Veterinary Anthrax Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Veterinary Anthrax Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Veterinary Anthrax Vaccines Sales Value Share by Application (2021-2032) Figure 19. Global Veterinary Anthrax Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Veterinary Anthrax Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Veterinary Anthrax Vaccines Sales Value (2021-2032) & (US$ Million) Figure 22. North America Veterinary Anthrax Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Veterinary Anthrax Vaccines Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Veterinary Anthrax Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Veterinary Anthrax Vaccines Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Veterinary Anthrax Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Veterinary Anthrax Vaccines Sales Value (2021-2032) & (US$ Million) Figure 28. South America Veterinary Anthrax Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Veterinary Anthrax Vaccines Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Veterinary Anthrax Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Cell Free PA Vaccines
  • Live Vaccines
Applications
  • Cow
  • Sheep
  • Swine
  • Other
Companies covered
  • JOVAC
  • Intervac (PVT) Ltd
  • Institute for Biological Products
  • Indian Immunologicals Limited
  • Empresa Colombiana de Productos Veterinarios S.A
  • Colorado Serum Company
  • Ceva Sante Animale
  • Centro Diagnostico Veterinario
  • Central Veterinary Control and Research Institute
  • Botswana Vaccine Institute
  • Biogenesis Bago SA
  • Bayer Sanidad Animal
  • Agrovet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Veterinary Anthrax Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Veterinary Anthrax Vaccines Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Veterinary Anthrax Vaccines Market Dynamics
  1. 2.1 Veterinary Anthrax Vaccines Industry Trends
  2. 2.2 Veterinary Anthrax Vaccines Industry Drivers
  3. 2.3 Veterinary Anthrax Vaccines Industry Opportunities and Challenges
  4. 2.4 Veterinary Anthrax Vaccines Industry Restraints
3 Veterinary Anthrax Vaccines Market by Company
  1. 3.1 Global Veterinary Anthrax Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary Anthrax Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary Anthrax Vaccines Company Ranking (2024-2026)
  4. 3.4 Global Veterinary Anthrax Vaccines Company Manufacturing Base and Headquarters
  5. 3.5 Global Veterinary Anthrax Vaccines Company Product Type and Application
  6. 3.6 Global Veterinary Anthrax Vaccines Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Veterinary Anthrax Vaccines Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Veterinary Anthrax Vaccines Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Veterinary Anthrax Vaccines Market by Type
  1. 4.1 Veterinary Anthrax Vaccines Type Introduction
  2. 4.1.1 Cell Free PA Vaccines
  3. 4.1.2 Live Vaccines
  4. 4.2 Global Veterinary Anthrax Vaccines Sales Value by Type
  5. 4.2.1 Global Veterinary Anthrax Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Veterinary Anthrax Vaccines Sales Value by Type (2021-2032)
  7. 4.2.3 Global Veterinary Anthrax Vaccines Sales Value Share by Type (2021-2032)
5 Veterinary Anthrax Vaccines Market by Application
  1. 5.1 Veterinary Anthrax Vaccines Application Introduction
  2. 5.1.1 Cow
  3. 5.1.2 Sheep
  4. 5.1.3 Swine
  5. 5.1.4 Other
  6. 5.2 Global Veterinary Anthrax Vaccines Sales Value by Application
  7. 5.2.1 Global Veterinary Anthrax Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Veterinary Anthrax Vaccines Sales Value by Application (2021-2032)
  9. 5.2.3 Global Veterinary Anthrax Vaccines Sales Value Share by Application (2021-2032)
6 Veterinary Anthrax Vaccines Regional Value Analysis
  1. 6.1 Global Veterinary Anthrax Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Anthrax Vaccines Sales Value by Region (2021-2032)
  3. 6.2.1 Global Veterinary Anthrax Vaccines Sales Value by Region: 2021-2026
  4. 6.2.2 Global Veterinary Anthrax Vaccines Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Veterinary Anthrax Vaccines Sales Value (2021-2032)
  7. 6.3.2 North America Veterinary Anthrax Vaccines Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Veterinary Anthrax Vaccines Sales Value (2021-2032)
  10. 6.4.2 Europe Veterinary Anthrax Vaccines Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Veterinary Anthrax Vaccines Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Veterinary Anthrax Vaccines Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Veterinary Anthrax Vaccines Sales Value (2021-2032)
  16. 6.6.2 South America Veterinary Anthrax Vaccines Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Veterinary Anthrax Vaccines Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Veterinary Anthrax Vaccines Sales Value Share by Country, 2025 VS 2032
7 Veterinary Anthrax Vaccines Country-level Value Analysis
  1. 7.1 Global Veterinary Anthrax Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary Anthrax Vaccines Sales Value by Country (2021-2032)
  3. 7.2.1 Global Veterinary Anthrax Vaccines Sales Value by Country (2021-2026)
  4. 7.2.2 Global Veterinary Anthrax Vaccines Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Veterinary Anthrax Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Veterinary Anthrax Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Veterinary Anthrax Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 JOVAC
  2. 8.1.1 JOVAC Company Information
  3. 8.1.2 JOVAC Business Overview
  4. 8.1.3 JOVAC Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  5. 8.1.4 JOVAC Veterinary Anthrax Vaccines Product Portfolio
  6. 8.1.5 JOVAC Recent Developments
  7. 8.2 Intervac (PVT) Ltd
  8. 8.2.1 Intervac (PVT) Ltd Company Information
  9. 8.2.2 Intervac (PVT) Ltd Business Overview
  10. 8.2.3 Intervac (PVT) Ltd Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Intervac (PVT) Ltd Veterinary Anthrax Vaccines Product Portfolio
  12. 8.2.5 Intervac (PVT) Ltd Recent Developments
  13. 8.3 Institute for Biological Products
  14. 8.3.1 Institute for Biological Products Company Information
  15. 8.3.2 Institute for Biological Products Business Overview
  16. 8.3.3 Institute for Biological Products Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Institute for Biological Products Veterinary Anthrax Vaccines Product Portfolio
  18. 8.3.5 Institute for Biological Products Recent Developments
  19. 8.4 Indian Immunologicals Limited
  20. 8.4.1 Indian Immunologicals Limited Company Information
  21. 8.4.2 Indian Immunologicals Limited Business Overview
  22. 8.4.3 Indian Immunologicals Limited Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Indian Immunologicals Limited Veterinary Anthrax Vaccines Product Portfolio
  24. 8.4.5 Indian Immunologicals Limited Recent Developments
  25. 8.5 Empresa Colombiana de Productos Veterinarios S.A
  26. 8.5.1 Empresa Colombiana de Productos Veterinarios S.A Company Information
  27. 8.5.2 Empresa Colombiana de Productos Veterinarios S.A Business Overview
  28. 8.5.3 Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Product Portfolio
  30. 8.5.5 Empresa Colombiana de Productos Veterinarios S.A Recent Developments
  31. 8.6 Colorado Serum Company
  32. 8.6.1 Colorado Serum Company Company Information
  33. 8.6.2 Colorado Serum Company Business Overview
  34. 8.6.3 Colorado Serum Company Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Colorado Serum Company Veterinary Anthrax Vaccines Product Portfolio
  36. 8.6.5 Colorado Serum Company Recent Developments
  37. 8.7 Ceva Sante Animale
  38. 8.7.1 Ceva Sante Animale Company Information
  39. 8.7.2 Ceva Sante Animale Business Overview
  40. 8.7.3 Ceva Sante Animale Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ceva Sante Animale Veterinary Anthrax Vaccines Product Portfolio
  42. 8.7.5 Ceva Sante Animale Recent Developments
  43. 8.8 Centro Diagnostico Veterinario
  44. 8.8.1 Centro Diagnostico Veterinario Company Information
  45. 8.8.2 Centro Diagnostico Veterinario Business Overview
  46. 8.8.3 Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Product Portfolio
  48. 8.8.5 Centro Diagnostico Veterinario Recent Developments
  49. 8.9 Central Veterinary Control and Research Institute
  50. 8.9.1 Central Veterinary Control and Research Institute Company Information
  51. 8.9.2 Central Veterinary Control and Research Institute Business Overview
  52. 8.9.3 Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Product Portfolio
  54. 8.9.5 Central Veterinary Control and Research Institute Recent Developments
  55. 8.10 Botswana Vaccine Institute
  56. 8.10.1 Botswana Vaccine Institute Company Information
  57. 8.10.2 Botswana Vaccine Institute Business Overview
  58. 8.10.3 Botswana Vaccine Institute Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Botswana Vaccine Institute Veterinary Anthrax Vaccines Product Portfolio
  60. 8.10.5 Botswana Vaccine Institute Recent Developments
  61. 8.11 Biogenesis Bago SA
  62. 8.11.1 Biogenesis Bago SA Company Information
  63. 8.11.2 Biogenesis Bago SA Business Overview
  64. 8.11.3 Biogenesis Bago SA Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Biogenesis Bago SA Veterinary Anthrax Vaccines Product Portfolio
  66. 8.11.5 Biogenesis Bago SA Recent Developments
  67. 8.12 Bayer Sanidad Animal
  68. 8.12.1 Bayer Sanidad Animal Company Information
  69. 8.12.2 Bayer Sanidad Animal Business Overview
  70. 8.12.3 Bayer Sanidad Animal Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Bayer Sanidad Animal Veterinary Anthrax Vaccines Product Portfolio
  72. 8.12.5 Bayer Sanidad Animal Recent Developments
  73. 8.13 Agrovet
  74. 8.13.1 Agrovet Company Information
  75. 8.13.2 Agrovet Business Overview
  76. 8.13.3 Agrovet Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Agrovet Veterinary Anthrax Vaccines Product Portfolio
  78. 8.13.5 Agrovet Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst